Trials / Completed
CompletedNCT00429520
Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds
Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (planned)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronic acid filler/IMD1 basic |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-12-01
- First posted
- 2007-01-31
- Last updated
- 2008-02-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00429520. Inclusion in this directory is not an endorsement.